Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
China Shineway Pharmaceutical Group Limited · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2027 | $22.82B | $22.82B - $22.82B | $6.55B | $0.00 | 1 |
| Dec 2026 | $21.21B | $21.21B - $21.21B | $6.09B | $0.00 | 1 |
| Dec 2025 | $22.30B | $22.30B - $22.30B | $6.41B | $0.00 | 1 |
| Dec 2024 | $29.58B | $26.95B - $32.21B | $8.50B | $0.00 | 2 |